Combination of chiral linkers with thiophenecarboximidamide heads to improve the selectivity of inhibitors of neuronal nitric oxide synthase
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
R01 GM057353
NIGMS NIH HHS - United States
R01 GM052419
NIGMS NIH HHS - United States
GM52419
NIGMS NIH HHS - United States
GM049725
NIGMS NIH HHS - United States
GM057353
NIGMS NIH HHS - United States
R01 GM049725
NIGMS NIH HHS - United States
PubMed
25149509
PubMed Central
PMC4204799
DOI
10.1016/j.bmcl.2014.07.079
PII: S0960-894X(14)00814-2
Knihovny.cz E-resources
- Keywords
- Heme, Nitric oxide synthase, Protein crystallography, Selective inhibition, Tetrahydrobiopterin, Thiophenecarboximidamide,
- MeSH
- Imides chemical synthesis chemistry pharmacology MeSH
- Enzyme Inhibitors chemical synthesis chemistry pharmacology MeSH
- Models, Molecular MeSH
- Molecular Structure MeSH
- Nitric Oxide Synthase Type I antagonists & inhibitors metabolism MeSH
- Thiophenes chemical synthesis chemistry pharmacology MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
- Names of Substances
- Imides MeSH
- Enzyme Inhibitors MeSH
- Nitric Oxide Synthase Type I MeSH
- Thiophenes MeSH
To develop potent and selective nNOS inhibitors, a new series of double-headed molecules with chiral linkers that derive from natural amino acid derivatives have been designed and synthesized. The new structures integrate a thiophenecarboximidamide head with two types of chiral linkers, presenting easy synthesis and good inhibitory properties. Inhibitor (S)-9b exhibits a potency of 14.7 nM against nNOS and is 1134 and 322-fold more selective for nNOS over eNOS and iNOS, respectively. Crystal structures show that the additional binding between the aminomethyl moiety of 9b and propionate A on the heme and tetrahydrobiopterin (H4B) in nNOS, but not eNOS, contributes to its high selectivity. This work demonstrates the advantage of integrating known structures into structure optimization, and it should be possible to more readily develop compounds that incorporate bioavailability with these advanced features. Moreover, this integrative strategy is a general approach in new drug discovery.
See more in PubMed
Mustafa AK, Gadalla MM, Synder SH. Sci. Signal. 2009;2:1. PubMed PMC
Vallance P, Leiper J. Nature Rev. Drug Discovery. 2002;1:939. PubMed
Sims NR, Anderson MF. Neurochem. Int. 2002;40:511. PubMed
Miclescu A, Gordh T. Acta Anaesthesiol. Scand. 2009;53:1107. PubMed
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield AD, Stella AMG. Nature Rev. Neurosci. 2007;8:766. PubMed
Zhang L, Dawson VL, Dawson TM. Pharmacol. Ther. 2006;109:33. PubMed
Dorheim M-A, Tracey WR, Pollock JS, Grammas P. Biochem. Biophys. Res. Commun. 1994;205:659. PubMed
Norris PJ, Waldvogel HJ, Faull RLM, Love DR, Emson PC. Neuronsicence. 1996;72:1037. PubMed
Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Arterioscler. Thromb. 1994;14:753. PubMed
Maddaford S, Annedi SC, Ramnauth J, Rakhit S. Annu. Rep. Med. Chem. 2009;44:27.
Narayanan K, Spack L, McMillan K, Kilbourn RG, Hayward MA, Masters BSS, Griffith OW. J. Biol. Chem. 1995;270:11103. PubMed
Ji H, Erdal EP, Litzinger EA, Seo J, Zhu Y, Xue F, Fang J, Huang J, Silverman RB. Reitz AB, Choudhary MI, Atta-ur-Rahman, editors. In Frontiers in Medicinal Chemistry. Bentham Science. 2009;54:842.
Ijuin R, Umezawa N, Nagai S, Higuchi T. Bioorg. Med. Chem. Lett. 2005;15:2881. PubMed
Ji H, Gomez-Vidal JA, Martásek P, Roman LJ, Silverman RB. J. Med. Chem. 2006;49:6254. PubMed PMC
Ramnauth J, Speed J, Maddaford SP, Dove P, Annedi SC, Renton P, Rakhit S, Andrews J, Silverman S, Mladenova G, Zinghini S, Nair S, Catalano C, Lee DKH, Felice MD, Porreca FJ. Med. Chem. 2011;54:5562. PubMed PMC
Annedi SC, Ramnauth J, Maddaford SP, Renton P, Rakhit S, Mladenova G, Dove P, Silverman S, Andrews JS, Felice MD, Porreca F. J. Med. Chem. 2012;55:943. PubMed
Liang G, Neuenschwander K, Chen X, Wei L, Munson R, Francisco G, Scotese A, Shutske G, Black M, Sarhan S, Jiang J, Morize I, Vaz RJ. Med. Chem. Commun. 2011;2:201.
Silverman RB. Acc. Chem. Res. 2009;42:439. PubMed PMC
Jing Q, Li H, Chreifi G, Roman LJ, Martásek P, Poulos TL, Silverman RB. Bioorg. Med. Chem. Lett. 2013;23:5674. PubMed PMC
Jing Q, Li H, Roman LJ, Martásek P, Poulos TL, Silverman RB. ACS MedChemLett. 2014;5:56. PubMed PMC
Zhang ZG, Reif D, Macdonald J, Tang WX, Kamp DK, Gentile RJ, Shakespeare WC, Murray RJ, Chopp MJ. Cereb. Blood Flow Metab. 1996;16:599. PubMed
Salerno L, Sorrenti V, Di Giacomo C, Romeo G, Siracusa MA. Curr. Pharm. Des. 2002;8:177. PubMed
Kang S, Tang W, Li H, Chreifi G, Martásek P, Roman LJ, Poulos TL, Silverman RB. J. Med. Chem. 2014;57:4382. PubMed PMC